105 related articles for article (PubMed ID: 24893120)
21. Differences in metabolism of the marine biotoxin okadaic acid by human and rat cytochrome P450 monooxygenases.
Kolrep F; Hessel S; These A; Ehlers A; Rein K; Lampen A
Arch Toxicol; 2016 Aug; 90(8):2025-36. PubMed ID: 26374342
[TBL] [Abstract][Full Text] [Related]
22. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
[TBL] [Abstract][Full Text] [Related]
23. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
Parikh A; Guengerich FP
Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
[TBL] [Abstract][Full Text] [Related]
24. Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.
Quehl P; Hollender J; Schüürmann J; Brossette T; Maas R; Jose J
Microb Cell Fact; 2016 Feb; 15():26. PubMed ID: 26838175
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
26. High-level expression of human cytochrome P450 1A2 by co-expression with human molecular chaperone HDJ-1(Hsp40).
Ahn T; Yang S; Yun CH
Protein Expr Purif; 2004 Jul; 36(1):48-52. PubMed ID: 15177283
[TBL] [Abstract][Full Text] [Related]
27. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
[TBL] [Abstract][Full Text] [Related]
28. Purification of cytochromes P450: products of bacterial recombinant expression systems.
Guengerich FP; Martin MV
Methods Mol Biol; 2006; 320():31-7. PubMed ID: 16719372
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of human cytochrome P450 1A2 by co-expression with human molecular chaperone Hsp70.
Ahn T; Yang S; Yun CH
Toxicol Lett; 2004 Nov; 153(2):267-72. PubMed ID: 15451558
[TBL] [Abstract][Full Text] [Related]
31. Cloning, expression and functional characterization of cytochrome P450 3A37 from turkey liver with high aflatoxin B1 epoxidation activity.
Rawal S; Yip SS; Coulombe RA
Chem Res Toxicol; 2010 Aug; 23(8):1322-9. PubMed ID: 20707407
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
33. Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation.
Ohyama K; Murayama N; Shimizu M; Yamazaki H
Xenobiotica; 2014 Jan; 44(1):10-6. PubMed ID: 23777257
[TBL] [Abstract][Full Text] [Related]
34. Improving the activity of surface displayed cytochrome P450 enzymes by optimizing the outer membrane linker.
Quehl P; Schüürmann J; Hollender J; Jose J
Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):104-116. PubMed ID: 27814979
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of four allelic variants of human cytochrome P450 1A2.
Zhou H; Josephy PD; Kim D; Guengerich FP
Arch Biochem Biophys; 2004 Feb; 422(1):23-30. PubMed ID: 14725854
[TBL] [Abstract][Full Text] [Related]
36. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by anti-tumor triazoloacridinone C-1305.
Potęga A; Fedejko-Kap B; Mazerska Z
Xenobiotica; 2016 Dec; 46(12):1056-1065. PubMed ID: 26928326
[TBL] [Abstract][Full Text] [Related]
38. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression.
Palma BB; Silva E Sousa M; Vosmeer CR; Lastdrager J; Rueff J; Vermeulen NP; Kranendonk M
Pharmacogenomics J; 2010 Dec; 10(6):478-88. PubMed ID: 20125119
[TBL] [Abstract][Full Text] [Related]
40. Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2.
Josephy PD; Bibeau KL; Evans DH
Environ Mol Mutagen; 2000; 35(4):328-35. PubMed ID: 10861951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
